Andrea Flynn | Head-Investor Relations |
Bruce Cozadd | Chairman and Chief Executive Officer |
Dan Swisher | President |
Rob Iannone | Executive Vice President, Global Head-R&D |
Renee Gala | Executive Vice President and Chief Financial Officer |
Kim Sablich | Executive Vice President and General Manager-North America |
Ken Cacciatore | Cowen |
Jessica Fye | JPMorgan |
Jason Gerberry | Bank of America |
Marc Goodman | SVB Leerink |
Brandon Folkes | Cantor Fitzgerald |
Jeff Hung | Morgan Stanley |
Balaji Prasad | Barclays |
Rob Palermo | Goldman Sachs |
Gary Nachman | BMO Capital Markets |
David Amsellem | Piper Sandler |
Annabel Samimy | Stifel |
Oren Livnat | H. C. Wainwright |
Greg Fraser | Truist Securities |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Jazz Pharmaceuticals First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, this conference call is being recorded.